UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RPRX — Royalty Pharma plc
CIK 861177
NEW YORK, NY
Position in RPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$148,503,890
+$27,990,953 QoQ
Shares Held
3,095,766
-0.7% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. RPRX ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $148,503,890 | 3,095,766 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $120,512,937 | 3,118,865 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $110,424,136 | 3,129,936 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $146,894,268 | 4,076,999 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $88,656,181 | 2,847,934 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $66,884,305 | 2,621,886 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $84,083,558 | 2,972,201 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $73,765,507 | 2,797,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $56,601,264 | 1,863,723 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,691,314 | 1,484,205 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,545,660 | 1,346,561 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,566,175 | 1,157,000 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $41,686,706 | 1,157,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $43,104,500 | 1,090,701 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $41,361,570 | 1,029,407 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,375,332 | 936,616 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $36,559,320 | 938,381 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,489,923 | 915,682 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,327,620 | 590,139 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,505,096 | 573,435 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $22,593,150 | 517,954 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||